123330 — Genic Co Income Statement
0.000.00%
- KR₩189bn
- KR₩179bn
- KR₩78bn
Annual income statement for Genic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38,408 | 31,449 | 28,070 | 49,908 | 78,198 |
| Cost of Revenue | |||||
| Gross Profit | 6,918 | 2,699 | 3,234 | 11,611 | 22,545 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 42,352 | 34,977 | 32,093 | 43,885 | 63,203 |
| Operating Profit | -3,944 | -3,528 | -4,023 | 6,024 | 14,996 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4,199 | -3,340 | -4,411 | 5,682 | 14,815 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4,199 | -3,340 | -4,411 | 7,563 | 18,887 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -4,331 | -3,340 | -4,411 | 7,563 | 18,887 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4,331 | -3,340 | -4,411 | 7,563 | 18,887 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -613 | -436 | -643 | 1,036 | 2,412 |
| Dividends per Share |